Human aldehyde dehydrogenase-catalyzed oxidation of ethylene glycol ether aldehydes

Chemico-Biological Interactions

Volumn 178, Issue 1-3, 2009, Pages 56-63

  Gross, Aaron ^a   Ong, Ta Ren ^a   Grant, Rainer ^a   Hoffmann, Todd ^a   Gregory, Daniel D ^a   Sreerama, Lakshmaiah ^a  

^a ST CLOUD STATE UNIVERSITY   (United States)

Author keywords

Aldehyde dehydrogenases (ALDHs); Bio activation; Ethylene glycol ether aldehydes (EGE aldehydes); Ethylene glycol ethers (EGEs); Metabolism

Indexed keywords

ACID; ALDEHYDE DEHYDROGENASE; ALDEHYDE DERIVATIVE; ALKYL GROUP; COMPLEMENTARY DNA; ETHYLENE GLYCOL ETHER; PROTON; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; ENZYME ACTIVITY; ENZYME METABOLISM; ENZYME SUBSTRATE; ENZYME SYNTHESIS; ESCHERICHIA COLI; MOLECULAR CLONING; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SWERN OXIDATION; TISSUE DISTRIBUTION;

ALDEHYDE DEHYDROGENASE; ALDEHYDES; BIOCATALYSIS; CHROMATOGRAPHY, ION EXCHANGE; CLONING, MOLECULAR; DNA, COMPLEMENTARY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ETHERS; ETHYLENE GLYCOL; HUMANS; OXIDATION-REDUCTION; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY;

ANIMALIA;

EID: 59049098270     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2008.09.025     Document Type: Article

References (68)

1. Miller R.R. Metabolism and disposition of glycol ethers. Drug Metab. Rev. 18 (1987) 1-22
2. Johanson G. Aspects of biological monitoring of exposure to glycol ethers. Toxicol. Lett. 43 (1988) 5-21
3. Johanson G. Toxicity review of ethylene glycol monomethyl ether and its acetate ester. Crit. Rev. Toxicol. 30 (2000) 307-345
4. Ghanayem B.I., Burka L.T., and Matthews H.B. Metabolic basis of ethylene glycol monobutyl ether (2-butoxyethanol) toxicity: Role of alcohol and aldehyde dehydrogenases. J. Pharmacol. Exp. Ther. 242 (1987) 222-231
5. Anon., NIOSH criteria for a recommended standard, monographs: occupational exposure to ethylene glycol monobutyl ether, and ethylene glycol monobutyl ether acetate. Cincinnati, OH, US Department of Health and Human Services, National Institute for Occupational Safety and Health, Division of Standards Development and Technology Transfer, 1990.
6. Anon. NTP toxicology and carcinogenesis studies of 2-butoxyethanol (CAS 111-76-2) in F344/N rats and B6C3F1 mice (inhalation studies). Natl. Toxicol. Program Tech. Rep. Ser. 484 (2000) 1-290
7. Browning R.G., and Curry S.C. Clinical toxicology of ethylene glycol ethers. Hum. Exp. Toxicol. 13 (1994) 325-335
8. Cullen M.R., Rado T., Waldron J.A., Sparer J., and Welch L.S. Bone marrow injury in lithographers exposed to glycol ethers and organic solvents used in multicolor offset and ultraviolet curing printing process. Arch. Environ. Health 38 (1983) 347-354
9. Laitinen J. Correspondence between occupational exposure limit and biological action level values for alkoxyethanols and their acetates. Int. Arch. Occup. Environ. Health 71 (1998) 117-124
10. Franks S.J., Spendiff M.K., Cocker J., and Loizou G.D. Physiologically based pharmacokinetic modeling of human exposure to 2-butoxyethanol. Toxicol. Lett. 162 (2006) 164-173
11. Dieter M. NTP technical report on the toxicity studies of ethyleneglycol ethers: 2-methoxyethanol, 2-ethoxyethanol, 2-butoxyethanol (CAS Nos. 109-86-4, 110-80-5, 111-76.2) administered in drinking water to F344/N rats and B6C3F1 mice. Toxicol. Rep. Ser. 26 (1993) 1-15
12. Staples C.A., Boatman R.J., and Cano M.L. Ethylene glycol ethers: an environmental risk assessment. Chemosphere 36 (1998) 1585-1613
13. Cogliano V.J., Grosse Y., Baan R.A., Straif K., Secretan M.B., and El-Ghissassi F. Meeting report: summary of IARC monographs on formaldehyde, 2-butoxyethanol, and 1-tert-butoxy-2-propanol. Environ. Health Perspect. 113 (2005) 1205-1208
14. Nitter-Hauge S. Poisoning ethylene glycol monomethyl ether: report of two cases. Acta Med. Scand. 188 (1970) 277-280
15. Gijsenbergh F.P., Jenco M., Veulemans H., Groesenken D., Verberckmoes R., and Delooz H.H. Acute butylglycol intoxication: a case report. Human Toxicol. 8 (1989) 243-245
16. Correa A., Gray R.H., Cohen R., Rothman N., Shah F., Seacat H., and Com M. Ethylene glycol ethers and risks of spontaneous abortion and subfertility. Am. J. Epidemiol. 143 (1996) 707-717
17. Multigner L., Ben Brik E., Arnaud I., Haguenoer J.M., Jouannet P., Auger J., and Eustache F. Glycol ethers and semen quality: a cross-sectional study among male workers in the Paris municipality. Occup. Environ. Med. 64 (2007) 467-473
18. Kalf G.F., Post G.B., and Snyder R. Solvent toxicology: recent advances in the toxicology of benzene, the glycol ethers, and carbon tetrachloride. Annu. Rev. Pharmacol. Toxicol. 27 (1987) 399-427
19. Green T., Toghill A., Lee R., Moore R., and Foster J. The development of forestomach tumors in the mouse following exposure to 2-butoxyethanol by inhalation: studies on the mode of action and relevance to humans. Toxicology 180 (2002) 257-273
20. Poet T.S., Soelberg J.J., Weitz K.K., Mast T.J., Miller R.A., Thrall B.D., and Corley R.A. Mode of action and pharmacokinetic studies of 2-butoxyethanol in the mouse with an emphasis on forestomach dosimetry. Toxicol. Sci. 71 (2003) 176-189
21. Corthals S.M., Kamendulis L.M., and Klaunig J.E. Mechanisms of 2-butoxyethanol-induced hemangiosarcomas. Toxicol. Sci. 92 (2006) 378-386
22. Long P.H., Maronpot R.R., Ghanayem B.I., Roycroft J.H., and Nyska A. Dental pulp infraction in female rats following inhalation exposure to 2-butoxyethanol. Toxicol. Pathol. 28 (2000) 246-252
23. Nyska A., Maronpot R.R., and Ghanayem B.I. Ocular thrombosis and retinal degeneration induced in female F344 rats by 2-butoxyethanol. Hum. Exp. Toxicol. 18 (1999) 577-582
24. Ghanayem B.I., Burka L.T., Sanders J.M., and Matthews H.B. Metabolism and disposition of ethylene glycol monobutyl ether (2butoxyethanol) in rats. Drug Metab. Dispos. 15 (1987) 478-484
25. Ghanayem B.I., Ward S.M., Chanas B., and Nyska A. Comparison of acute hematotoxicity of 2-butoxyethanol in male and female F344 rats. Hum. Exp. Toxicol. 19 (2000) 185-192
26. Ghanayem B.I., and Sullivan C.A. Assessment of hemolytic activity of 2-butoxyethanol and its major metabolite, butoxyacetic acid, in various mammals including humans. Human Exp. Toxicol. 12 (1993) 305-311
27. Udden M.M. Rat erythrocyte morphological changes after gavage dosing with 2-butoxyethanol: a comparison with the in vitro effects of butoxyacetic acid on rat and human erythrocytes. J. Appl. Toxicol. 20 (2000) 381-387
28. Dugard P.H., Walker M., Mawdsley S.J., and Scott R.C. Absorption of some glycol ethers through human skin in vitro. Environ. Health Perspect. 57 (1984) 193-197
29. Kumagai S., Oda H., Matsunaga I., Kosaka H., and Akasaka S. Uptake of 10 polar organic solvents during short-term respiration. Toxicol. Sci. 48 (1999) 255-263
30. Wilkinson S.C., and Williams F.M. Effects of experimental conditions on absorption of glycol ethers through human skin in vitro. Int. Arch. Occup. Environ. Health 75 (2002) 519-527
31. Traynor M.J., Wilkinson S.C., and Williams F.M. Metabolism of butoxyethanol in excised human skin in vitro. Toxicol. Lett. 177 (2008) 151-155
32. Dill J.A., Lee K.M., Bates D.J., Anderson D.J., Johnson R.E., Chou B.J., Burka L.T., and Roycroft H. Toxicokinetics of inhaled 2-butoxyethanol and its major metabolite, 2-butoxyacetic acid, in F344 rats and B6C3F1 mice. Toxicol. Appl. Pharmacol. 153 (1998) 227-242
33. Aasmoe L., and Aarbakke J. Sex-dependent induction of alcohol dehydrogenase activity in rats. Biochem. Pharmacol. 57 (1999) 1067-1072
34. Aasmoe L., Winberg J.-O., and Aarbakke J. The role of liver alcohol dehydrogenase isozymes in the oxidation of glycolethers in male and female rats. Toxicol. Appl. Pharmacol. 150 (1998) 86-90
35. Roper C.S., Howes D., Blain P.G., and Williams F.M. Percutaneous penetration of 2-phenoxyethanol through rat and human skin. Food Chem. Toxicol. 35 (1997) 1009-1016
36. Lockley D.J., Howes D., and Williams F.M. Percutaneous penetration and metabolism of 2-butoxyethanol. Arch. Toxicol. 78 (2004) 617-628
37. Lockley D.J., Howes D., and Williams F.M. Cutaneous metabolism of glycol ethers. Arch. Toxicol. 79 (2005) 160-168
38. Kezic S., Meuling W.J.A., and Jakasa I. Free and total urinary 2-butoxyacetic acid following dermal and inhalation exposure to 2-butoxyethanol in human volunteers. Int. Arch. Occup. Environ. Health 77 (2004) 580-586
39. Lovold A., Smith N., Kuyomba U., Reberg A., Gregory D., and Sreerama L. Role of human aldehyde dehydrogenases in ethylene glycol ether metabolism: oxidation of 2-butoxyethanal and 2-phenoxyethanal. In: Weiner H., Plapp B., Lindahl R., and Maser E. (Eds). Enzymology and Molecular Biology of Carbonylmetabolism-12 (2005), Purdue University Press, West Lafayette, IN 15-26
40. Ghanayem B.I., Sanders J.M., Clark A.M., Bailer J., and Matthews H.B. Effects of dose, age, inhibition of metabolism and elimination on the toxicokinetics of 2-butoxyethanol and its metabolites. Exp. Ther. Pharmacol. 253 (1990) 36-143
41. Moslen M.T., Kaphalia L., Balasubramanian H., Yin Y.-M., and Wu W.W. Species differences in testicular and hepatic biotransformation of 2-methoxyethanol. Toxicology 96 (1995) 217-224
42. Goedde H.W., and Agarwal D.P. Pharmacogenetics of aldehyde dehydrogenase. Pharmacol. Ther. 45 (1990) 345-371
43. Edenberg H.J., and Bosron W.F. Alcohol dehydrogenases. In: Guengrich F.P. (Ed). Comprehensive Toxicology vol. 3: Biotransformation (1997), Pergamon, New York 119-131
44. Rivoros-Rosas H., Julian-Sanchez A., and Pina E. Enzymology of ethanol and acetaldehyde metabolism in mammals. Arch. Med. Res. 28 (1997) 453-471
45. Sladek N.E. Human aldehyde dehydrogenases: potential pathological, pharmacological, and toxicological impact. J. Biochem. Mol. Toxicol. 17 (2003) 7-23
46. Sophos N.A., Black W.J., and Vasiliou V. Aldehyde dehydrogenase gene superfamily. In: Weiner H., Plapp B., Lindahl R., and Maser E. (Eds). Enzymology and Molecular Biology of Carbonylmetabolism-12 (2005), Purdue University Press, West Lafayette, IN 3-7
47. Sreerama L., and Sladek N.E. Aldehyde dehydrogenases: measurement of activities and protein levels. In: Hodgson E. (Ed). Current Protocols in Toxicology (2005), John Wiley, New York, NY 4.18.1-4.18.59
48. Sreerama L., and Sladek N.E. Identification and characterization of a novel class 3 aldehyde dehydrogenase overexpressed in a human breast adenocarcinoma cell line exhibiting oxazaphosphorine-specific acquired resistance. Biochem. Pharmacol. 45 (1993) 2487-2505
49. Sreerama L., and Sladek N.E. Class 1 and class 3 aldehyde dehydrogenase levels in the human tumor cell lines currently used by the National Cancer Institute to screen for potentially useful antitumor agents. Adv. Exp. Med. Biol. 414 (1997) 81-94
50. Sreerama L., and Sladek N.E. Three different stable human breast adenocarcinoma sublines that overexpress ALDH3A1 and certain other enzymes as consequence of constitutively upregulated gene transcription mediated by transactivated EpREs (electrophile responsive elements) present in the 5'-upstream regions of these genes. Chem. Biol. Interact. 130 (2001) 247-260
51. Devaraj V.R., Sreerama L., Lee M.J.C., Nagasawa H.T., and Sladek N.E. Yeast aldehyde dehydrogenase sensitivity to inhibition by chlorpropamide analogues as an indicator of human aldehyde dehydrogenase sensitivity to these agents. Adv. Exp. Med. Biol. 414 (1997) 155-169
52. Moreb J., Schweder M., Suresh A., and Zucali J.R. Overexpression of the human aldehyde dehydrogenase class I results in increased resistance to 4-hydroperoxycyclophosphamide. Cancer Gene Ther. 3 (1996) 24-30
53. Zheng C.-F., Wang T.T.Y., and Weiner H. Cloning and expression of the full-length cDNAs encoding human liver class 1 and class 2 aldehyde dehydrogenases. Alcohol. Clin. Exp. Res. 17 (1993) 828-831
54. Dockham P.A., Lee M.-O., and Sladek N.E. Identification of human liver aldehyde dehydrogenases that catalyze the oxidation of aldophosphamide and retinaldehyde. Biochem. Pharmacol. 43 (1992) 2453-2469
55. Sreerama L., Rekha G.K., and Sladek N.E. Phenolic antioxidant-induced overexpression of class-3 aldehyde dehydrogenase and oxazaphosphorine-specific resistance. Biochem. Pharmacol. 49 (1995) 669-675
56. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
57. Yoshida A., Rzhetsky A., Hsu L.C., and Chang C.-P. Human aldehyde dehydrogenase gene family. Eur. J. Biochem. 251 (1998) 549-557
58. Lindahl R. Aldehyde dehydrogenases and their role in carcinogenesis. Crit. Rev. Biochem. Mol. Biol. 27 (1992) 283-335
59. Sreerama L., and Sladek N.E. Identification of a methylcholanthrene-induced aldehyde dehydrogenase in a human breast adenocarcinoma cell line exhibiting oxazaphosphorine-specific acquired resistance. Cancer Res. 54 (1994) 2176-2185
60. Sreerama L., Hedge M.W., and Sladek N.E. Identification of a class-3 aldehyde dehydrogenase in human saliva and increased levels of this enzyme, glutathione S-transferase and DT-diaphorase in the saliva of subjects who ingest large quantities of coffee and broccoli. Clin. Cancer Res. 1 (1995) 1153-1163
61. Sladek N.E., Sreerama L., and Rekha G.K. Constitutive and overexpressed human cytosolic class 3 aldehyde dehydrogenases in normal and neoplastic cells/secretions. Adv. Exp. Med. Biol. 372 (1995) 103-114
62. Sreerama L., Grant R., Gross A., and Gregory D. Polymorphic human class-3 aldehyde dehydrogenases. In: Weiner H., Plapp B., Lindahl R., and Maser E. (Eds). Enzymology and Molecular Biology of Carbonylmetabolism-13 (2007), Purdue University Press, West Lafayette, IN 53-64
63. Chambliss K.L., Caudle D.L., Hinson D.D., Moomaw C.R., Slaughter C.A., Jakobs C., and Gibson K.M. Molecular cloning of the mature NAD(+)-dependent succinic semialdehyde dehydrogenase from rat and human: cDNA isolation, evolutionary homology, and tissue expression. J. Biol. Chem. 270 (1995) 461-467
64. Murphy T.C., Amarnath V., and Picklo M.J. Mitochondrial oxidation of 4-hydroxy-2-nonenal in rat cerebral cortex. J. Neurochem. 84 (2003) 1313-1321
65. Kitagawa K., Kawamoto T., Kunugita N., Tsukiyama T., Okamotoc K., Yoshidad A., and Nakayamab K.K. Nakayama Aldehyde dehydrogenase (ALDH) 2 associates with oxidation of methoxyacetaldehyde in vitro analysis with liver subcellular fraction derived from human and Aldh2 gene targeting mouse. FEBS Lett. 476 (2000) 306-311
66. Salad M., Grant R., Reberg A., and Sreerama L. Detoxification of chloroacetaldehyde by human class-9 aldehyde dehydrogenase (ALDH9A1). In: Weiner H., Plapp B., Lindahl R., and Maser E. (Eds). Enzymology and Molecular Biology of Carbonylmetabolism-13 (2007), Purdue University Press, West Lafayette, IN 44-52
67. Peachey J.E. A review of the clinical use of disulfiram and calcium carbimide in alcoholism treatment. J. Clin. Psychopharmacol. 1 (1981) 368-375
68. Cheung C., Davies N.G., Hoog J.-O., Hotchkiss S.A.M., and Smith Pease C.K. Species variations in cutaneous alcohol dehydrogenases and aldehyde dehydrogenases may impact on toxicological assessments of alcohols and aldehydes. Toxicology 184 (2003) 97-112